GMEB-SASS

· CHU de Quebec-Universite Laval

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GMEB-SASS, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment [Phase 1, Phase 2]